Search research articles
Contact Us
Filters
Showing results (31-40 of 86) with videos related to
Page
of 9
Sort By:
The Lancet. Psychiatry
|
July 31, 2025
Infection, inflammation, and personalisation: time for an integrated approach to clozapine monitoring
Scott R Clark, Catharine Toben, Magdalene C Jawahar, et al.
Molecular Psychiatry
|
May 13, 2021
From multivariate methods to an AI ecosystem
Nils R Winter, Micah Cearns, Scott R Clark, et al.
The Lancet. Psychiatry
|
December 1, 2023
Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study
Korinne Northwood, Nicholas Myles, Scott R Clark, et al.
The Australian and New Zealand Journal of Psychiatry
|
December 1, 2021
Clozapine, mRNA COVID-19 vaccination and drug-induced myocarditis
Jessica L Dawson, Scott R Clark, Lisa R Wilton, et al.
Journal of Diabetes Investigation
|
August 6, 2025
The relationship between depressive symptoms and glycemic control is stronger in women with type 2 diabetes in South Asians: Results from a cross-sectional multicenter study
Md Kamruzzaman, Jessica A Marathe, Karen L Jones, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 10, 2021
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
Bernhard T Baune, Emma Sampson, Jennie Louise, et al.
Pharmacological Research
|
December 28, 2024
IUPHAR themed review: The gut microbiome in schizophrenia
Srinivas Kamath, Elysia Sokolenko, Kate Collins, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 5, 2022
Corrigendum to 'No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial' [European Neuropsychopharmacology 53 (2021) 34-46]
Bernhard T Baune, Emma Sampson, Jennie Louise, et al.
Acta Biomaterialia
|
October 22, 2017
Determining the effects of PEI adsorption on the permeability of 1,2-dipalmitoylphosphatidylcholine/bis(monoacylglycero)phosphate membranes under osmotic stress
Scott R Clark, Keel Yong Lee, Hoyoung Lee, et al.
The Journal of Clinical Psychiatry
|
October 5, 2023
Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Emma Sampson, Natalie T Mills, Hikaru Hori, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 86) with videos related to
Sort By:
Page
of 9
The Lancet. Psychiatry
|
July 31, 2025
Infection, inflammation, and personalisation: time for an integrated approach to clozapine monitoring
Scott R Clark, Catharine Toben, Magdalene C Jawahar, et al.
Molecular Psychiatry
|
May 13, 2021
From multivariate methods to an AI ecosystem
Nils R Winter, Micah Cearns, Scott R Clark, et al.
The Lancet. Psychiatry
|
December 1, 2023
Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study
Korinne Northwood, Nicholas Myles, Scott R Clark, et al.
The Australian and New Zealand Journal of Psychiatry
|
December 1, 2021
Clozapine, mRNA COVID-19 vaccination and drug-induced myocarditis
Jessica L Dawson, Scott R Clark, Lisa R Wilton, et al.
Journal of Diabetes Investigation
|
August 6, 2025
The relationship between depressive symptoms and glycemic control is stronger in women with type 2 diabetes in South Asians: Results from a cross-sectional multicenter study
Md Kamruzzaman, Jessica A Marathe, Karen L Jones, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 10, 2021
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
Bernhard T Baune, Emma Sampson, Jennie Louise, et al.
Pharmacological Research
|
December 28, 2024
IUPHAR themed review: The gut microbiome in schizophrenia
Srinivas Kamath, Elysia Sokolenko, Kate Collins, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 5, 2022
Corrigendum to 'No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial' [European Neuropsychopharmacology 53 (2021) 34-46]
Bernhard T Baune, Emma Sampson, Jennie Louise, et al.
Acta Biomaterialia
|
October 22, 2017
Determining the effects of PEI adsorption on the permeability of 1,2-dipalmitoylphosphatidylcholine/bis(monoacylglycero)phosphate membranes under osmotic stress
Scott R Clark, Keel Yong Lee, Hoyoung Lee, et al.
The Journal of Clinical Psychiatry
|
October 5, 2023
Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Emma Sampson, Natalie T Mills, Hikaru Hori, et al.
Page
of 9